Cover Image

Population Pharmacokinetic–Pharmacodynamic Modeling of Granulocyte Colony‐Stimulating Factor to Optimize Dosing and Timing for CD34+ Cell Harvesting

Fuente: Wiley Open Access

Saved in:

Bibliographic Details
Main Authors:	Xu Jiang, Jun Seok Cha, Byung Hak Jin, Choon Ok Kim, Dongwoo Chae
Format:	Artículo Open Access
Published:	Wiley 2025
Subjects:	Clinical and Translational Science
Online Access:	Acceder al recurso
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Pharmacokinetics, pharmacodynamics, and safety of izuforant, an H4R inhibitor, in healthy subjects: A phase I single and multiple ascending dose study
by: Byung Hak Jin, et al.
Published: (2024)

Population Pharmacokinetic and Pharmacodynamic Prediction for Tebipenem Pivoxil Treatment of Pediatric Shigellosis
by: Cindy X. Zhang, et al.
Published: (2025)

Translational Pharmacokinetic‐Pharmacodynamic Modeling and Efficacious Human Dose Prediction of DNDI ‐6148 for the Treatment of Cutaneous Leishmaniasis
by: Rasmus Hansen Henninger, et al.
Published: (2026)

Emapalumab in Patients With Macrophage Activation Syndrome Associated With Still's Disease: A Population Pharmacokinetic/Pharmacodynamic Analysis
by: Patrick Brossard
Published: (2025)

Pharmacokinetic‐Pharmacodynamic Model of Paclitaxel‐Induced Peripheral Neuropathy
by: Yuchen Sun, et al.
Published: (2025)

Population Pharmacokinetic Model‐Based Optimization of Linezolid Dosing in Hematooncological Patients With Suspected or Proven Gram‐Positive Sepsis
by: Alžběta Zavřelová, et al.
Published: (2025)

Population Pharmacokinetic and Pharmacokinetic‐Pharmacodynamic Modeling of Serum M‐Protein Response for Modakafusp Alfa in a Phase 1/2 Study of Patients With Relapsed or Refractory Multiple Myeloma
by: Cheryl Li, et al.
Published: (2025)

Ethnic Sensitivity Assessment of Mosunetuzumab Pharmacokinetics and Pharmacodynamics in Chinese Patients With Relapsed or Refractory Follicular Lymphoma
by: Junyi Li, et al.
Published: (2025)

Evaluation of Innate Immune System, Body Habitus, and Sex on the Pharmacokinetics and Pharmacodynamics of Anetumab Ravtansine in Patients With Cancer
by: Li Chen, et al.
Published: (2025)

Evaluation of a Therapeutic Drug Monitoring Strategy for Adalimumab in Psoriasis: A Prospective Pharmacokinetic‐Pharmacodynamic Study
by: Shan Pan, et al.
Published: (2026)

Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of ALXN1820 (Tarperprumig) in Healthy Adults: Results of a Phase I Study
by: Avner Sandhu, et al.
Published: (2025)

First‐in‐Human Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ASP1617, a Cathepsin‐S Inhibitor, in Healthy Adult Subjects
by: Tomoki Kojima, et al.
Published: (2026)

Population Pharmacokinetics and Exposure–Response Analysis of Serplulimab in Small Cell Lung Cancer Patients
by: Kun Wang, et al.
Published: (2025)

Model‐Informed Optimal Dosing of Anti‐CD47 Antibody Using Target‐Mediated Drug Disposition Model
by: Seongmee Jeong, et al.
Published: (2025)

Granulocyte colony‐stimulating factor induced T‐cell hyporesponsiveness via modulation of CD177 + S100A hi neutrophils in unexplained recurrent pregnancy loss
by: Ping‐Fen Li, et al.
Published: (2025)

Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of INT‐787, a Novel Farnesoid X Receptor Agonist, in Healthy Volunteers: A Phase 1 Trial
by: Thomas Capozza, et al.
Published: (2025)

Pharmacokinetics and Safety of Fixed‐Dose Versus Separate Enavogliflozin/Gemigliptin Combinations, and Food Effect on Enavogliflozin in Healthy Korean Subjects
by: Young‐Sim Choi, et al.
Published: (2025)

Pharmacokinetics and Toxicity of Dimethylacetamide and Its Metabolite in Pediatric Patients Treated With High Dose Intravenous Busulphan
by: Fadwa Benkessou, et al.
Published: (2025)

Elexacaftor/Tezacaftor/Ivacaftor Population Pharmacokinetics in Pediatric Patients With Cystic Fibrosis
by: Ngoc Hoa Truong, et al.
Published: (2025)

Real‐World Impact of Amiodarone on Apixaban Population Pharmacokinetics in Hospitalized Patients
by: Samantha Kolowrat, et al.
Published: (2025)

Bayesian Population Pharmacokinetic Modeling of Ondansetron for Neonatal Opioid Withdrawal Syndrome
by: Kevin Lam, et al.
Published: (2025)

Phase 1 Study Evaluating the Pharmacokinetics, Dose Proportionality, Bioavailability, and Tolerability of Subcutaneous Levothyroxine Sodium (XP‐8121)
by: Richard Fitch, et al.
Published: (2025)

A Phase 1 Multiple‐Dose, Open‐Label, Pharmacokinetic Study of Nirmatrelvir/Ritonavir in Healthy Lactating Women
by: Jacqueline Gerhart, et al.
Published: (2026)

Pharmacokinetic interactions between fexuprazan, a potassium‐competitive acid blocker, and nonsteroidal anti‐inflammatory drugs in healthy males
by: Heejae Won, et al.
Published: (2024)

Predicting Vancomycin Clearance in Neonates and Infants by Integrating Machine Learning and Metabolomics With Population Pharmacokinetics
by: Hui Yu, et al.
Published: (2025)

Utilization of Machine Learning Approaches for Drug Clearance Prediction and Population Pharmacokinetic Covariate Analysis
by: Atul Rawal, et al.
Published: (2025)

Challenges in Extrapolating Healthy Volunteer Pharmacokinetics to Oncology Populations: Advocating for a Holistic Perspective
by: Yan Ji, et al.
Published: (2025)

Population Pharmacokinetics and Exposure–Response Analyses for Capivasertib in Combination With Fulvestrant in Patients With Breast Cancer
by: Carlos Fernandez Teruel, et al.
Published: (2025)

Impacts of Pharmacokinetic Gene Polymorphisms on Steady‐State Plasma Concentrations of Simvastatin in Thai Population
by: Sayanit Tipnoppanon, et al.
Published: (2025)

Physiologically Based Pharmacokinetic Modeling of Valemetostat to Inform Dose Recommendations When Coadministered With CYP3A /P‐gp Modulators
by: Akiko Watanabe, et al.
Published: (2025)

Genetics of Response to Canagliflozin ( GRC ) Study: Rationale, Design, and Pharmacodynamic Responses
by: May E. Montasser, et al.
Published: (2026)

Pharmacokinetics and Safety of Single and Multiple Doses of Molnupiravir in Healthy Male Chinese Adults: An Open‐Label, Fixed Sequence, Phase 1 Study
by: Jixiang Zhu, et al.
Published: (2026)

The Beta‐Blocker Pharmacogenetic Puzzle: More Pieces of Evidence for Pharmacodynamic Candidate Variants
by: Jasmine A. Luzum, et al.
Published: (2025)

Population pharmacokinetics and CD20 binding dynamics for mosunetuzumab in relapsed/refractory B‐cell non‐Hodgkin lymphoma
by: Brendan Bender, et al.
Published: (2024)

Predicting the Pharmacokinetics of T‐Cell Engagers as a Function of Target‐Mediated Drug Disposition
by: Mark Penney, et al.
Published: (2025)

The Pharmacokinetic Interaction Between Metformin and the Natural Product Goldenseal Is Metformin Dose‐Dependent: A Three‐Arm Crossover Study in Adults With Type 2 Diabetes
by: James T. Nguyen, et al.
Published: (2025)

Population Pharmacokinetics of Vancomycin in Critically Ill Patients Undergoing Continuous Renal Replacement Therapy: Influence of Adsorptive Membranes
by: Chidtawan Hirunsomboon, et al.
Published: (2026)

Population Pharmacokinetic Model Assessment of the Effects of Body Weight on Risk of Drug–Drug Interactions After Posaconazole Discontinuation
by: Rebecca E. Wrishko, et al.
Published: (2026)

Pharmacokinetics as a Biomarker
by: John A. Wagner, et al.
Published: (2026)

Genotype–Specific Safety and Pharmacokinetics of Cannabidiol in Healthy Volunteers
by: Jumar Etkins, et al.
Published: (2025)